News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
304,917 Results
Type
Article (11674)
Company Profile (13)
Press Release (293230)
Multimedia
Podcasts (17)
Webinars (4)
Section
Business (86021)
Career Advice (566)
Deals (20451)
Drug Delivery (38)
Drug Development (42062)
Employer Resources (58)
FDA (8622)
Job Trends (7242)
News (160158)
Policy (16433)
Tag
2024 BioMidwest Digital (1)
2024 Biotech Bay Standard (3)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (1)
Academia (826)
Accelerated approval (2)
Adcomms (7)
Allergies (45)
Alliances (19509)
ALS (36)
Alzheimer's disease (655)
Antibody-drug conjugate (ADC) (41)
Approvals (8697)
Artificial intelligence (102)
Autoimmune disease (9)
Automation (7)
Bankruptcy (182)
Best Places to Work (5984)
BIOSECURE Act (7)
Biosimilars (52)
Biotechnology (10)
Bladder cancer (52)
Brain cancer (12)
Breast cancer (140)
Cancer (1149)
Cardiovascular disease (85)
Career advice (500)
Career pathing (12)
CAR-T (55)
Cell therapy (197)
Cervical cancer (15)
Clinical research (35762)
Collaboration (363)
Compensation (135)
Complete response letters (11)
COVID-19 (1104)
CRISPR (17)
C-suite (94)
Cystic fibrosis (52)
Data (1431)
Decentralized trials (2)
Denatured (4)
Depression (15)
Diabetes (138)
Diagnostics (3054)
Digital health (8)
Diversity (2)
Diversity, equity & inclusion (17)
Drug discovery (45)
Drug pricing (51)
Drug shortages (9)
Duchenne muscular dystrophy (50)
Earnings (41824)
Editorial (22)
Employer branding (3)
Employer resources (49)
Events (40079)
Executive appointments (316)
FDA (9356)
Featured Employer (3)
Friedreich's ataxia (1)
Frontotemporal dementia (5)
Funding (303)
Gene editing (43)
Generative AI (11)
Gene therapy (148)
GLP-1 (298)
Government (2093)
Grass and pollen (2)
Guidances (49)
Healthcare (8253)
Huntington's disease (9)
IgA nephropathy (18)
Immunology and inflammation (35)
Indications (23)
Infectious disease (1169)
Inflammatory bowel disease (76)
Inflation Reduction Act (4)
Influenza (26)
Intellectual property (59)
Interviews (66)
IPO (11322)
IRA (25)
Job creations (1570)
Job search strategy (450)
Kidney cancer (5)
Labor market (21)
Layoffs (166)
Leadership (6)
Legal (3069)
Liver cancer (33)
Lung cancer (177)
Lymphoma (88)
Machine learning (2)
Management (22)
Manufacturing (144)
MASH (38)
Medical device (6557)
Medtech (6559)
Mergers & acquisitions (9566)
Metabolic disorders (316)
Multiple sclerosis (46)
NASH (10)
Neurodegenerative disease (30)
Neuropsychiatric disorders (9)
Neuroscience (887)
NextGen: Class of 2025 (2371)
Non-profit (1140)
Northern California (1502)
Now hiring (5)
Obesity (150)
Opinion (82)
Ovarian cancer (40)
Pain (43)
Pancreatic cancer (48)
Parkinson's disease (59)
Partnered (10)
Patents (145)
Patient recruitment (62)
Peanut (23)
People (21942)
Pharmaceutical (9)
Pharmacy benefit managers (18)
Phase I (9910)
Phase II (15289)
Phase III (13462)
Pipeline (816)
Policy (86)
Postmarket research (1217)
Preclinical (3718)
Press Release (8)
Prostate cancer (58)
Psychedelics (16)
Radiopharmaceuticals (109)
Rare diseases (177)
Real estate (2495)
Recruiting (21)
Regulatory (12526)
Reports (16)
Research institute (715)
Resumes & cover letters (58)
Rett syndrome (4)
RNA editing (1)
RSV (17)
Schizophrenia (23)
Series A (41)
Series B (29)
Service/supplier (3)
Sickle cell disease (22)
Southern California (1244)
Special edition (4)
Spinal muscular atrophy (74)
Sponsored (8)
Startups (1055)
State (1)
Stomach cancer (2)
Supply chain (29)
Tariffs (20)
The Weekly (13)
United States (11927)
Vaccines (302)
Venture capitalists (12)
Weight loss (79)
Women's health (8)
Worklife (7)
Date
Today (77)
Last 7 days (451)
Last 30 days (1354)
Last 365 days (17592)
2025 (5574)
2024 (18758)
2023 (21731)
2022 (27432)
2021 (29349)
2020 (27474)
2019 (20271)
2018 (15395)
2017 (15930)
2016 (13385)
2015 (16760)
2014 (11831)
2013 (8925)
2012 (9971)
2011 (10438)
2010 (9363)
Location
Africa (278)
Alabama (19)
Alaska (2)
Arizona (63)
Arkansas (4)
Asia (19418)
Australia (2561)
California (3298)
Canada (1073)
China (273)
Colorado (120)
Connecticut (121)
Delaware (77)
Europe (45122)
Florida (547)
Georgia (101)
Idaho (14)
Illinois (227)
India (15)
Indiana (195)
Iowa (3)
Japan (83)
Kansas (61)
Kentucky (3)
Louisiana (1)
Maine (42)
Maryland (472)
Massachusetts (2148)
Michigan (84)
Minnesota (175)
Mississippi (1)
Missouri (35)
Montana (4)
Nebraska (10)
Nevada (39)
New Hampshire (39)
New Jersey (1053)
New Mexico (4)
New York (1020)
North Carolina (410)
North Dakota (1)
Northern California (1502)
Ohio (76)
Oklahoma (5)
Oregon (15)
Pennsylvania (780)
Puerto Rico (5)
Rhode Island (14)
South America (471)
South Carolina (10)
Southern California (1244)
Tennessee (38)
Texas (416)
Utah (103)
Virginia (87)
Washington D.C. (36)
Washington State (310)
West Virginia (1)
Wisconsin (17)
304,917 Results for "european commission ec".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Samsung Bioepis Gains European Commission (EC) Approval for Denosumab Biosimilar (OBODENCE™, XBRYK™)
February 17, 2025
·
4 min read
Press Releases
European Commission (EC) Approves Merck’s CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults
March 27, 2025
·
14 min read
Press Releases
Samsung Bioepis and Biogen Receive European Commission (EC) Approval for Aflibercept Biosimilar, OPUVIZ™
November 18, 2024
·
8 min read
Press Releases
European Commission (EC) Extends the Approval of Evkeeza® (evinacumab) to Children as Young as 6-months Old with Homozygous Familial Hypercholesterolemia (HoFH)
January 6, 2025
·
10 min read
Press Releases
Krystal Biotech Announces European Commission Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
April 29, 2025
·
5 min read
Press Releases
Pharvaris Announces Orphan Designation Granted to Deucrictibant by the European Commission
April 1, 2025
·
6 min read
Europe
With Tariffs Looming, EU and US Pharmas Make Demands of European Commission
Playing both sides of trade war, pharma companies are asking for certain compensations for scientific innovation and a smoother regulatory framework.
April 16, 2025
·
2 min read
·
Tristan Manalac
Biotech Beach
Arcturus Therapeutics Receives Orphan Medicinal Product Designation from the European Commission (EC), for ARCT-032, for the Treatment of Cystic Fibrosis
Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT) today announced that the European Commission (EC), based on a positive opinion issued by the European Medicines Agency (EMA), has granted orphan medicinal product designation for the Company’s product candidate ARCT-032 to treat Cystic Fibrosis (CF).
February 22, 2024
·
5 min read
Europe
Biogen, Eisai Continue Leqembi’s European Rally as CHMP Reaffirms Positive Opinion
Leqembi’s application now moves forward to the European Commission, which will issue a formal verdict for the injection that will apply to all EU member states as well as Norway, Liechtenstein and Iceland.
March 3, 2025
·
2 min read
·
Tristan Manalac
Job Trends
HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by Takeda
HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that its partner Takeda (TSE:4502/NYSE:TAK) has received notification from the European Commission (“EC”) that it has approved FRUZAQLA®.
June 21, 2024
·
17 min read
1 of 30,492
Next
